Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
A new double-antibody sandwich ELISA targeting Plasmodium falciparum aldolase to evaluate anti-malarial drug sensitivity
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 533192
Author(s) Tritten, Lucienne; Matile, Hugues; Brun, Reto; Wittlin, Sergio
Author(s) at UniBasel Brun, Reto
Wittlin, Sergio
Year 2009
Title A new double-antibody sandwich ELISA targeting Plasmodium falciparum aldolase to evaluate anti-malarial drug sensitivity
Journal Malaria Journal
Volume 8
Pages / Article-Number 226
Abstract BACKGROUND: The standard in vitro test to assess anti-malarial activity of chemical compounds is the [3H]hypoxanthine incorporation assay. It is a radioactivity-based method to measure DNA replication of Plasmodium in red blood cells. The method is highly reproducible, however, the handling of radioactive material is costly, hazardous and requires the availability of appropriate technology and trained staff. Several other ways to evaluate in vitro anti-malarial activity do exist, all with their own assets and limitations. METHODS: The newly developed double-antibody sandwich ELISA described here is based on the properties of a non-overlapping pair of monoclonal antibodies directed against Plasmodium falciparum aldolase. This glycolytic enzyme possesses some unique nucleotide sequences compared to the human isoenzymes and has been highly conserved through evolution. Out of twenty possibilities, the most sensitive antibody pair was selected and used to quantitatively detect parasite aldolase in infected blood lysates. RESULTS: A total of 34 compounds with anti-malarial activity were tested side-by-side by ELISA and the [3H]hypoxanthine incorporation assay. The novel ELISA provided IC 50s closely paralleling those from the radioactivity-based assay (R = 0.99, p < 0.001). At the investigated assay conditions (72 h incubation time, parasitaemia = 0.3%), the assay was found to be reproducible and easy to perform. CONCLUSION: The newly developed ELISA presents several advantages over the comparative method, the [3H]hypoxanthine incorporation assay. The assay is highly reproducible, less hazardous (involves no radioactivity) and requires little and cheap technical equipment. Relatively unskilled personnel can conduct this user-friendly assay. All this makes it attractive to be employed in resource-poor laboratories
Publisher BioMed Central
ISSN/ISBN 1475-2875
edoc-URL http://edoc.unibas.ch/dok/A5843120
Full Text on edoc No
Digital Object Identifier DOI 10.1186/1475-2875-8-226
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/19821995
ISI-Number WOS:000271601400001
Document type (ISI) Journal Article
 
   

MCSS v5.8 PRO. 0.414 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
19/04/2024